OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
Lars Erik Kristensen, Bruce Strober, Denis Poddubnyy, et al.
Therapeutic Advances in Musculoskeletal Disease (2023) Vol. 15
Open Access | Times Cited: 12
Lars Erik Kristensen, Bruce Strober, Denis Poddubnyy, et al.
Therapeutic Advances in Musculoskeletal Disease (2023) Vol. 15
Open Access | Times Cited: 12
Showing 12 citing articles:
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis
Bruce Strober, Laura C. Coates, Mark Lebwohl, et al.
Drug Safety (2023) Vol. 47, Iss. 1, pp. 39-57
Open Access | Times Cited: 25
Bruce Strober, Laura C. Coates, Mark Lebwohl, et al.
Drug Safety (2023) Vol. 47, Iss. 1, pp. 39-57
Open Access | Times Cited: 25
Analysis of tofacitinib safety in ulcerative colitis from the completed global clinical developmental program up to 9.2 years of drug exposure
Julián Panés, Geert R. D’Haens, Bruce E. Sands, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 6, pp. 793-801
Open Access | Times Cited: 14
Julián Panés, Geert R. D’Haens, Bruce E. Sands, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 6, pp. 793-801
Open Access | Times Cited: 14
Inhibition of the JAK-STAT Pathway in the Treatment of Psoriasis: A Review of the Literature
Andreea Roxana Furtunescu, Simona Roxana Georgescu, Mircea Tampa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4681-4681
Open Access | Times Cited: 10
Andreea Roxana Furtunescu, Simona Roxana Georgescu, Mircea Tampa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4681-4681
Open Access | Times Cited: 10
Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access | Times Cited: 1
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access | Times Cited: 1
Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease
Ignacio Marín‐Jiménez, Daniel Carpio, Vicent Hernández, et al.
Gastroenterología y Hepatología (English Edition) (2025), pp. 502314-502314
Closed Access
Ignacio Marín‐Jiménez, Daniel Carpio, Vicent Hernández, et al.
Gastroenterología y Hepatología (English Edition) (2025), pp. 502314-502314
Closed Access
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
Lars Erik Kristensen, Atul Deodhar, Ying Ying Leung, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 3, pp. 487-499
Open Access | Times Cited: 4
Lars Erik Kristensen, Atul Deodhar, Ying Ying Leung, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 3, pp. 487-499
Open Access | Times Cited: 4
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Cardiometabolic Risk in Psoriatic Arthritis: A Hidden Burden of Inflammation and Metabolic Dysregulation
Mislav Radić, Andrej Belančić, Hana Đogaš, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 206-206
Open Access
Mislav Radić, Andrej Belančić, Hana Đogaš, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 206-206
Open Access
Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients
Xiaona Ma, Mei-Feng Shi, Shiow‐Ing Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Xiaona Ma, Mei-Feng Shi, Shiow‐Ing Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Managing psoriatic arthritis in different clinical scenarios
Rubén Queiró, Marta Loredo, Ignacio Braña, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1469-1484
Closed Access | Times Cited: 3
Rubén Queiró, Marta Loredo, Ignacio Braña, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1469-1484
Closed Access | Times Cited: 3
Psoriatic arthritis - Tofacitinib as a new treatment
Marta Skorupska, Magdalena Joanna Czeczotka, Martyna Magdalena Martka, et al.
Journal of Education Health and Sport (2024) Vol. 73, pp. 51686-51686
Open Access
Marta Skorupska, Magdalena Joanna Czeczotka, Martyna Magdalena Martka, et al.
Journal of Education Health and Sport (2024) Vol. 73, pp. 51686-51686
Open Access
Treatment controversies in spondyloarthritis and psoriatic arthritis: focus on biologics and targeted therapies
Fadi Kharouf, Dafna D. Gladman
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 11, pp. 1381-1400
Closed Access
Fadi Kharouf, Dafna D. Gladman
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 11, pp. 1381-1400
Closed Access
Efficacy of tofacitinib in psoriatic arthritis: literature review and case report
Г. И. Гриднева, E. S. Aronova
Meditsinskiy sovet = Medical Council (2023), Iss. 21, pp. 143-150
Open Access
Г. И. Гриднева, E. S. Aronova
Meditsinskiy sovet = Medical Council (2023), Iss. 21, pp. 143-150
Open Access
